|
FANCD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.459800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.785570E-02 |
| Normal-vs-Stage2 |
9.738000E-01 |
| Normal-vs-Stage3 |
3.330300E-02 |
| Normal-vs-Stage4 |
7.678200E-03 |
| Stage1-vs-Stage2 |
1.661010E-03 |
| Stage1-vs-Stage3 |
8.238600E-01 |
| Stage1-vs-Stage4 |
2.327000E-01 |
| Stage2-vs-Stage3 |
5.701000E-03 |
| Stage2-vs-Stage4 |
1.116830E-03 |
| Stage3-vs-Stage4 |
2.285600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.068010E-02 |
| Normal-vs-AfricanAmerican |
2.370100E-02 |
| Normal-vs-Asian |
2.279700E-02 |
| Caucasian-vs-AfricanAmerican |
6.230000E-01 |
| Caucasian-vs-Asian |
9.918400E-01 |
| AfricanAmerican-vs-Asian |
6.436000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.153900E-02 |
| Normal-vs-Female |
2.420300E-02 |
| Male-vs-Female |
8.607600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.844000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.073440E-01 |
| Normal-vs-Age(61-80Yrs) |
1.098970E-01 |
| Normal-vs-Age(81-100Yrs) |
2.804400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.862200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.071900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.964600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.741800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.465600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.182600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.538420E-01 |
| Classical-VS-Follicular |
1.83286719135367E-12 |
| Classical-VS-Other |
2.019200E-01 |
| Classical-VS-Normal |
2.358300E-03 |
| Tall-VS-Follicular |
2.37370000322201E-08 |
| Tall-VS-Other |
4.697800E-02 |
| Tall-VS-Normal |
5.155800E-04 |
| Follicular-VS-Other |
2.674800E-01 |
| Follicular-VS-Normal |
4.277200E-01 |
| Other-VS-Normal |
7.021400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.848840E-01 |
| Normal-vs-N1 |
2.323500E-02 |
| N0-vs-N1 |
7.161900E-02 |
|
|
